Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 2
1947 3
1948 2
1950 1
1951 2
1952 3
1953 2
1954 1
1955 2
1956 3
1957 4
1958 7
1959 13
1960 31
1961 62
1962 76
1963 172
1964 293
1965 201
1966 229
1967 316
1968 370
1969 408
1970 482
1971 635
1972 627
1973 753
1974 821
1975 857
1976 834
1977 797
1978 917
1979 904
1980 850
1981 939
1982 1021
1983 1159
1984 1310
1985 1334
1986 1295
1987 1313
1988 1268
1989 1476
1990 1523
1991 1518
1992 1458
1993 1535
1994 1479
1995 1473
1996 1562
1997 1522
1998 1501
1999 1526
2000 1646
2001 1657
2002 1652
2003 1702
2004 1591
2005 1849
2006 1897
2007 1969
2008 1893
2009 1975
2010 2060
2011 2238
2012 2342
2013 2289
2014 2310
2015 2381
2016 2274
2017 2168
2018 2225
2019 2299
2020 2517
2021 2562
2022 2369
2023 2185
2024 774

Text availability

Article attribute

Article type

Publication date

Search Results

82,055 results

Results by year

Filters applied: . Clear all
Page 1
Cyclophosphamide and cancer: golden anniversary.
Emadi A, Jones RJ, Brodsky RA. Emadi A, et al. Nat Rev Clin Oncol. 2009 Nov;6(11):638-47. doi: 10.1038/nrclinonc.2009.146. Epub 2009 Sep 29. Nat Rev Clin Oncol. 2009. PMID: 19786984 Review.
Cyclophosphamide remains one of the most successful and widely utilized antineoplastic drugs. ...It was initially synthesized to selectively target cancer cells, although the hypothesized mechanism of tumor specificity (activation by cancer cell phosphamidases) transpired …
Cyclophosphamide remains one of the most successful and widely utilized antineoplastic drugs. ...It was initially synthesized to sele …
Cyclophosphamide in dermatology.
Kim J, Chan JJ. Kim J, et al. Australas J Dermatol. 2017 Feb;58(1):5-17. doi: 10.1111/ajd.12406. Epub 2016 Jan 24. Australas J Dermatol. 2017. PMID: 26806212 Review.
Cyclophosphamide is a chemotherapeutic agent which was first discovered in experimental tumours in rats, and it has since been widely used to treat malignancies and severe manifestations of various auto-immune diseases. ...This article reviews the current literature on …
Cyclophosphamide is a chemotherapeutic agent which was first discovered in experimental tumours in rats, and it has since been widely …
Cyclophosphamide cardiotoxicity.
Kumar S, Gupta RK, Samal N. Kumar S, et al. Natl Med J India. 1992 Jan-Feb;5(1):17-9. Natl Med J India. 1992. PMID: 1304238 Free article. Review. No abstract available.
[Cyclophosphamide].
Lorenz C, Jaehde U. Lorenz C, et al. Dtsch Med Wochenschr. 2001 Jul 13;126(28-29):815-8. doi: 10.1055/s-2001-15698. Dtsch Med Wochenschr. 2001. PMID: 11499264 Review. German. No abstract available.
Cyclophosphamide enfeebles myocardial isometric contraction force via RIP1/RIP3/MLKL/TRPM7-mediated necroptosis.
Abulfadl YS, El Ela YA, Al Khaiyat AM, Elkhodary KI, Badran M. Abulfadl YS, et al. Biomed Pharmacother. 2023 Jul;163:114819. doi: 10.1016/j.biopha.2023.114819. Epub 2023 May 3. Biomed Pharmacother. 2023. PMID: 37146416 Free article.
This study identifies necroptosis as a key factor in cyclophosphamide-evoked myocardial contractility impairment, highlighting its potential as a target for alleviating antitumor-related myocardial damage. This innovative approach to investigating the underlying mechanisms …
This study identifies necroptosis as a key factor in cyclophosphamide-evoked myocardial contractility impairment, highlighting its po …
Cyclophosphamide: use in practice.
Gershwin ME, Goetzl EJ, Steinberg AD. Gershwin ME, et al. Ann Intern Med. 1974 Apr;80(4):531-40. doi: 10.7326/0003-4819-80-4-531. Ann Intern Med. 1974. PMID: 4621265 Review. No abstract available.
Cyclophosphamide teratogenesis: a review.
Mirkes PE. Mirkes PE. Teratog Carcinog Mutagen. 1985;5(2):75-88. doi: 10.1002/tcm.1770050202. Teratog Carcinog Mutagen. 1985. PMID: 2859667 Review.
Cyclophosphamide (CP) is one of the best studied teratogens; it produces primarily central nervous system and skeletal anomalies in rats, mice, rabbits, monkeys, and humans. ...
Cyclophosphamide (CP) is one of the best studied teratogens; it produces primarily central nervous system and skeletal anomalies in r …
The development of post-transplant cyclophosphamide: Half a century of translational team science.
O'Donnell PV, Jones RJ. O'Donnell PV, et al. Blood Rev. 2023 Nov;62:101034. doi: 10.1016/j.blre.2022.101034. Epub 2022 Nov 13. Blood Rev. 2023. PMID: 36435690 Review.
Over half a century ago, investigators at Johns Hopkins found that cyclophosphamide's immunosuppressive properties made it the ideal replacement for total body irradiation in alloBMT conditioning regimens. ...Animal and extensive human studies demonstrated that high …
Over half a century ago, investigators at Johns Hopkins found that cyclophosphamide's immunosuppressive properties made it the …
Mechanisms of Graft-versus-Host Disease Prevention by Post-transplantation Cyclophosphamide: An Evolving Understanding.
Nunes NS, Kanakry CG. Nunes NS, et al. Front Immunol. 2019 Nov 29;10:2668. doi: 10.3389/fimmu.2019.02668. eCollection 2019. Front Immunol. 2019. PMID: 31849930 Free PMC article. Review.
Furthermore, these studies showed differences in the impact of cyclophosphamide on transplanted cells (tumor) versus tissue (skin grafts), including the ability of cyclophosphamide to prevent rejection of the former but not the latter after MHC-mismatched transplant …
Furthermore, these studies showed differences in the impact of cyclophosphamide on transplanted cells (tumor) versus tissue (skin gra …
Post-transplant high-dose cyclophosphamide for the prevention of graft-versus-host disease.
Al-Homsi AS, Roy TS, Cole K, Feng Y, Duffner U. Al-Homsi AS, et al. Biol Blood Marrow Transplant. 2015 Apr;21(4):604-11. doi: 10.1016/j.bbmt.2014.08.014. Epub 2014 Aug 23. Biol Blood Marrow Transplant. 2015. PMID: 25240817 Free article. Review.
Cyclophosphamide's lack of hematopoietic stem cell toxicity and its unique effects on the immune system have prompted several investigators to explore its potential for the prevention of graft-versus-host disease (GVHD). ...In matched related and unrelated donor set …
Cyclophosphamide's lack of hematopoietic stem cell toxicity and its unique effects on the immune system have prompted several …
82,055 results
You have reached the last available page of results. Please see the User Guide for more information.

Searches related to "cyclophosphamide"